Evidence map›Paper›PMID 34504071›Full record

ArticleNature communications2021

Digital immunoassay for biomarker concentration quantification using solid-state nanopores.

Liqun He, Daniel R Tessier, Kyle Briggs, Matthaios Tsangaris, Martin Charron, Erin M McConnell, Dmytro Lomovtsev, Vincent Tabard-Cossa

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 104 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Detection of protein oligomers with nanopores.Nature reviews. Chemistry · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Liqun He *Department of Physics, University of Ottawa, Ottawa, Canada.ORCID 0000-0002-7417-448X
Daniel R Tessier *Department of Physics, University of Ottawa, Ottawa, Canada.ORCID 0000-0002-9695-6204
Kyle BriggsDepartment of Physics, University of Ottawa, Ottawa, Canada.ORCID 0000-0002-0183-6585
Matthaios TsangarisDepartment of Physics, University of Ottawa, Ottawa, Canada.
Martin CharronDepartment of Physics, University of Ottawa, Ottawa, Canada.ORCID 0000-0002-1545-8650
Erin M McConnellDepartment of Physics, University of Ottawa, Ottawa, Canada.ORCID 0000-0001-7408-4057
Dmytro LomovtsevDepartment of Physics, University of Ottawa, Ottawa, Canada.ORCID 0000-0002-5172-6536
Vincent Tabard-CossaDepartment of Physics, University of Ottawa, Ottawa, Canada. tcossa@uOttawa.ca.ORCID 0000-0003-4375-717X
University of Ottawa · CA

Funding

Solid-state nanopores and silicon nanomembranes for ultrasensitive protein biomarker detectionR01EB031581 · NIBIB · UNIVERSITY OF ROCHESTER · PI FLAX, JONATHAN D, GODIN, MICHEL · 2021 to 2024
$1.7M
NIBIB NIH HHS R01 EB031581
6 · The paper itself

Abstract

Single-molecule counting is the most accurate and precise method for determining the concentration of a biomarker in solution and is leading to the emergence of digital diagnostic platforms enabling precision medicine. In principle, solid-state nanopores-fully electronic sensors with single-molecule sensitivity-are well suited to the task. Here we present a digital immunoassay scheme capable of reliably quantifying the concentration of a target protein in complex biofluids that overcomes specificity, sensitivity, and consistency challenges associated with the use of solid-state nanopores for protein sensing. This is achieved by employing easily-identifiable DNA nanostructures as proxies for the presence ("1") or absence ("0") of the target protein captured via a magnetic bead-based sandwich immunoassay. As a proof-of-concept, we demonstrate quantification of the concentration of thyroid-stimulating hormone from human serum samples down to the high femtomolar range. Further optimization to the method will push sensitivity and dynamic range, allowing for development of precision diagnostic tools compatible with point-of-care format.

Indexed as

NanoporesAlgorithmsBiomarkersBlood ProteinsDNAHumansImmunoassayNanotechnologyPrecision MedicineReproducibility of ResultsSensitivity and SpecificityThyrotropinBiomarkersBlood ProteinsDNAThyrotropin

Identifiers

PMID34504071
PMCPMC8429538
OpenAlexW3196438430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.